TigerConnect Dominates G2’s Summer 2024 Rankings, Securing Top Positions in Healthcare Technology SANTA MONICA, CA., July 30, 2024 — TigerConnect, the leading clinical collaboration platform in healthcare, has once again demonstrated its industry leadership by...
BrightInsight Expands its Partnership with Google Cloud to Enhance the Patient Journey Through Generative AI BrightInsight is modernizing its development processes and patient companion apps with Google’s Gemini models, MedLM, and Vertex AI SAN JOSE, Calif. –...
Iterum Therapeutics Commences Rights Offering DUBLIN and CHICAGO, July 22, 2024 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to...
Iterum Therapeutics Announces FDA Advisory Committee Meeting to discuss NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections Proposed Date for Advisory Committee meeting is September 9, 2024 DUBLIN, Ireland and CHICAGO, June 21, 2024...
Star Therapeutics Presents Clinical Data for VGA039, a Subcutaneous Therapy for the Treatment of Von Willebrand Disease (VWD) VGA039 clinical data supports favorable safety profile in healthy volunteers and convenient subcutaneous dosing regimen Oral presentation...
Electra Therapeutics Presents Late-Breaking Clinical Data at EHA2024 from Ongoing Phase 1b Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH) ELA026 demonstrated a high overall response rate (ORR) across a range of sHLH patients and a favorable...
Recent Comments